The Efficacy of Montelukast during the Allergy Season in Pediatric Patients with Persistent Asthma and Seasonal Aeroallergen Sensitivity

References

• Asher M I, Montefort S, Bjorksten B, Lai C K, Strachan D P, Weiland S K, Williams H. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368: 733–743
   PubMed Web of Science ®Google Scholar
• Rabe K F, Adachi M, Lai C K, Soriano J B, Vermeire P A, Weiss K B, Weiss S T. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004; 114: 40–47
   PubMed Web of Science ®Google Scholar
• Bacharier L B, Boner A, Carlsen K H, Eigenmann P A, Frischer T, Gotz M, Helms P J, Hunt J, Liu A, Papadopoulos N, Platts-Mills T, Pohunek P, Simons F E, Valovirta E, Wahn U, Wildhaber J. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008; 63: 5–34
   PubMed Web of Science ®Google Scholar
• Bisgaard H. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma. Allergy 2001; 56(suppl 66)7–11
   PubMed Web of Science ®Google Scholar
• Parameswaran K, Radford K, Fanat A, Stephen J, Bonnans C, Levy B D, Janssen L J, Cox P G. Modulation of human airway smooth muscle migration by lipid mediators and Th-2 cytokines. Am J Respir Cell Mol Biol 2007; 37: 240–247
   PubMedGoogle Scholar
• Lex C, Zacharasiewicz A, Payne D N, Wilson N M, Nicholson A G, Kharitonov S A, Barnes P J, Bush A. Exhaled breath condensate cysteinyl leukotrienes and airway remodeling in childhood asthma: a pilot study. Respir Res 2006; 7: 63
   PubMed Web of Science ®Google Scholar
• Storms W. Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction. Expert Opin Pharmacother 2007; 8: 2173–2187
   PubMed Web of Science ®Google Scholar
• Busse W W, Casale T B, Dykewicz M S, Meltzer E O, Bird S R, Hustad C M, Grant E, Zeldin R K, Edelman J M. Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity. Ann Allergy Asthma Immunol 2006; 96: 60–68
   PubMed Web of Science ®Google Scholar
• Knorr B, Matz J, Bernstein J A, Nguyen H, Seidenberg B C, Reiss T F, Becker A. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group. JAMA 1998; 279: 1181–1186
   PubMed Web of Science ®Google Scholar
• Kemeny M E, Rosenwasser L J, Panettieri R A, Rose R M, Berg-Smith S M, Kline J N. Placebo response in asthma: a robust and objective phenomenon. J Allergy Clin Immunol 2007; 119: 1375–1381
   PubMed Web of Science ®Google Scholar
• Leigh R, MacQueen G, Tougas G, Hargreave F E, Bienenstock J. Change in forced expiratory volume in 1 second after sham bronchoconstrictor in suggestible but not suggestion-resistant asthmatic subjects: a pilot study. Psychosom Med 2003; 65: 791–795
   PubMed Web of Science ®Google Scholar
• Joyce D P, Jackevicius C, Chapman K R, McIvor R A, Kesten S. The placebo effect in asthma drug therapy trials: a meta-analysis. J Asthma 2000; 37: 303–318
   PubMed Web of Science ®Google Scholar
• Chervinsky P, Philip G, Malice M P, Bardelas J, Nayak A, Marchal J L, van Adelsberg J, Bousquet J, Tozzi C A, Reiss T F. Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies. Ann Allergy Asthma Immunol 2004; 92: 367–373
   PubMed Web of Science ®Google Scholar
• Frequently asked questions about pollen forecasting and sampling for allergy alerts, Available at http://pollen.com/allergy-hay-fever-faq.asp Accessed October 8, 2008
   Google Scholar
• D'Amato G, Cecchi L, Bonini S, Nunes C, Annesi-Maesano I, Behrendt H, Liccardi G, Popov T, van Cauwenberge P. Allergenic pollen and pollen allergy in Europe. Allergy 2007; 62: 976–990
   PubMed Web of Science ®Google Scholar
• Tobias A, Galan I, Banegas J R, Arangues E. Short term effects of airborne pollen concentrations on asthma epidemic. Thorax 2003; 58: 708–710
   PubMed Web of Science ®Google Scholar
• Johnston N W, Mandhane P J, Dai J, Duncan J M, Greene J M, Lambert K, Sears M R. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy. Pediatrics 2007; 120: e702–712
   PubMed Web of Science ®Google Scholar
• Chipps B E, Spahn J D, Sorkness C A, Baitinger L, Sutton L B, Emmett A H, Dorinsky P M. Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting beta2-agonists. J Pediatr 2006; 148: 517–521
   PubMed Web of Science ®Google Scholar
• Juniper E F, Svensson K, O'Byrne P M, Barnes P J, Bauer C A, Lofdahl C G, Postma D S, Pauwels R A, Tattersfield A E, Ullman A. Asthma quality of life during 1 year of treatment with budesonide with or without formoterol. Eur Respir J 1999; 14: 1038–1043
   PubMed Web of Science ®Google Scholar
• Carranza R, Jr, Edwards L, Lincourt W, Dorinsky P, ZuWallack R L. The relationship between health-related quality of life, lung function and daily symptoms in patients with persistent asthma. Respir Med 2004; 98: 1157–1165
   PubMedGoogle Scholar
• Luskin A T. What the asthma end points we know and love do and do not tell us. J Allergy Clin Immunol 2005; 115: S539–S545
   PubMed Web of Science ®Google Scholar
• Bukstein D, Kraft M, Liu A H, Peters S P. Asthma end points and outcomes: what have we learned?. J Allergy Clin Immunol 2006; 118: S1–15
   PubMed Web of Science ®Google Scholar
• Cowen M K, Wakefield D B, Cloutier M M. Classifying asthma severity: objective versus subjective measures. J Asthma 2007; 44: 711–715
   PubMed Web of Science ®Google Scholar
• Patel P, Philip G, Yang W, Call R, Horak F, LaForce C, Gilles L, Garrett G C, Dass S B, Knorr B A, Reiss T F. Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis. Ann Allergy Asthma Immunol 2005; 95: 551–557
   PubMed Web of Science ®Google Scholar
• Philip G, Malmstrom K, Hampel F C, Weinstein S F, LaForce C F, Ratner P H, Malice M P, Reiss T F. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy 2002; 32: 1020–1028
   PubMed Web of Science ®Google Scholar
• Philip G, Nayak A S, Berger W E, Leynadier F, Vrijens F, Dass S B, Reiss T F. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin 2004; 20: 1549–1558
   PubMed Web of Science ®Google Scholar
• Philip G, Williams-Herman D, Patel P, Weinstein S F, Alon A, Gilles L, Tozzi C A, Dass S B, Reiss T F. Efficacy of montelukast for treating perennial allergic rhinitis. Allergy Asthma Proc 2007; 28: 296–304
   PubMed Web of Science ®Google Scholar
• van Adelsberg J, Philip G, LaForce C F, Weinstein S F, Menten J, Malice M P, Reiss T F. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2003; 90: 214–222
   PubMed Web of Science ®Google Scholar
• van Adelsberg J, Philip G, Pedinoff A J, Meltzer E O, Ratner P H, Menten J, Reiss T F. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period. Allergy 2003; 58: 1268–1276
   PubMed Web of Science ®Google Scholar
• Zeiger R S, Bird S R, Kaplan M S, Schatz M, Pearlman D S, Orav E J, Hustad C M, Edelman J M. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial. Am J Med 2005; 118: 649–657
   PubMed Web of Science ®Google Scholar